Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 473-474 [2019-00298]

Download as PDF Federal Register / Vol. 84, No. 20 / Wednesday, January 30, 2019 / Notices by the National Electrical Manufacturers Association (NEMA) which provided data and supporting factual information relating to rough service lamp sales.4 In its comments, NEMA provided the names of nine NEMA manufacturers and two non-member companies that sell rough service lamps. While NEMA did not take a position on the merits of Aero-Tech’s application, NEMA’s comments indicated that the demand for rough service lamps is decreasing as customers are migrating to lightemitting diode (LED) light bulbs for rough service applications at higher light output levels. amozie on DSK3GDR082PROD with NOTICES1 III. Consultation with Other Agencies Per 42 U.S.C. 6295(t)(2), DOE obtained the written views of the Attorney General concerning AeroTech’s application for exemption. Under this statutory provision, DOE may only grant a small business exemption if it has consulted with the Attorney General and finds that a lessening of competition would likely result. In its assessment letter responding to DOE, the Department of Justice (DOJ) concluded that failure to grant AeroTech’s application for a small business exemption for rough service lamps would likely not result in a lessening of competition. DOJ made this determination after reviewing AeroTech’s application, as well as speaking with industry representatives and reviewing the supplementary information submitted to DOE by industry representatives. As part of its analysis, DOJ noted that it applies the standard set forth in 42 U.S.C. 6295(t)(2), and examines whether failure to grant a small business exemption would likely result in a lessening of competition, for example, by substantially limiting consumer choice or increasing industry concentration. Daniel R. Simmons, Assistant Secretary, Energy Efficiency and Renewable Energy. [FR Doc. 2019–00303 Filed 1–29–19; 8:45 am] BILLING CODE 6450–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Five AHRQ Subcommittee Meetings Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of meetings. AGENCY: SUMMARY: The subcommittees listed in the DATES section of this notice are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. DATES: The dates for the five subcommittee meetings are as follows: 1. Healthcare Safety and Quality Improvement Research (HSQR) Date: February 6–7, 2019 (Open from 7:30 a.m. to 8 a.m. on February 6th and closed for remainder of the meeting) 2. Healthcare Effectiveness and Outcomes Research (HEOR) Date: February 13–14, 2019 (Open from 8:30 a.m. to 9 a.m. on February 13th and closed for remainder of the meeting) 3. Health System and Value Research (HSVR) Date: February 20–21, 2019 (Open from 8 a.m. to 8:30 a.m. on February 20th and closed for remainder of the meeting) IV. Order 4. Health Care Research and Training DOE has no independent basis to (HCRT) come to a different conclusion than the Date: February 21–22, 2019 (Open DOJ with regard to Aero-Tech’s request from 8 a.m. to 8:30 a.m. on February for a small business exemption. Thus, 21st and closed for remainder of the DOE does not find that Aero-Tech has meeting) demonstrated that a failure to allow the 5. Healthcare Information Technology exemption would result in a lessening Research (HITR) of competition, as required under 42 Date: February 28–March 1, 2019 U.S.C. 6295(t)(2). It is Ordered that the (Open from 8 a.m. to 8:30 a.m. on application for a small business February 28th and closed for exemption submitted on May 23, 2018 remainder of the meeting) by Aero-Tech Light Bulb Co. is denied. ADDRESSES: Each meeting will be held at Signed in Washington, DC, on January 17, the Hilton Rockville & Executive 2019. Meeting Center, 1750 Rockville Pike, lllllllllllllllllllll Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: To 4 NEMA’s comment can be accessed at: https:// obtain a roster of members, agenda, or www.regulations.gov/document?D=EERE-2018-BTPET-0016-0002. minutes of the non-confidential portions VerDate Sep<11>2014 16:22 Jan 29, 2019 Jkt 247001 PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 473 of the meetings, contact: Mrs. Heather Phelps, Acting Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427–1128. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committees. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018. SUPPLEMENTARY INFORMATION: Francis D. Chesley, Jr., Acting Deputy Director. [FR Doc. 2019–00259 Filed 1–29–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of closed meeting. In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). SUMMARY: E:\FR\FM\30JAN1.SGM 30JAN1 474 Federal Register / Vol. 84, No. 20 / Wednesday, January 30, 2019 / Notices The meeting will be held on March 14, 2019, 2:00 p.m. to 5:00 p.m., EDT (CLOSED). DATES: ADDRESSES: Teleconference. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. National Institutes of Health Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–3953, Email address: NCIPCBSC@cdc.gov. [FR Doc. 2019–00298 Filed 1–29–19; 8:45 am] The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Chief Operating Officer, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. Purpose: The Board of Scientific Counselors makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury and violence prevention. The Board also provides advice on the appropriate balance of intramural and extramural research, and guidance on the needs, structure, progress and performance of intramural programs. The Board also provides guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of secondary peer review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as they relate to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director relating to applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters to be Considered: The agenda will include discussions on Secondary Peer Review of extramural research grant and cooperative agreement applications received in response to one (1) Notice of Funding Opportunities (NOFO): CE19–001, Injury Control Research Centers. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Centers for Disease Control and Prevention SUPPLEMENTARY INFORMATION: amozie on DSK3GDR082PROD with NOTICES1 Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Sep<11>2014 16:22 Jan 29, 2019 Jkt 247001 BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP19–005, Research to Enhance the US Vision and Eye Health Surveillance System. Dates: March 28, 2019. Times: 11:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–00275 Filed 1–29–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, DDK–C Member Conflicts. Date: February 15, 2019. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jian Yang, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7111, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, yangj@ extra.niddk.nih.gov. This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: January 24, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–00292 Filed 1–29–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Pages 473-474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00298]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC).

[[Page 474]]


DATES: The meeting will be held on March 14, 2019, 2:00 p.m. to 5:00 
p.m., EDT (CLOSED).

ADDRESSES: Teleconference.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-3953, Email address: NCIPCBSC@cdc.gov.

SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Chief Operating Officer, 
Office of the Chief Operating Officer, CDC, pursuant to Public Law 92-
463.
    Purpose: The Board of Scientific Counselors makes recommendations 
regarding policies, strategies, objectives, and priorities; and reviews 
progress toward injury and violence prevention. The Board also provides 
advice on the appropriate balance of intramural and extramural 
research, and guidance on the needs, structure, progress and 
performance of intramural programs. The Board also provides guidance on 
extramural scientific program matters, including the: (1) Review of 
extramural research concepts for funding opportunity announcements; (2) 
conduct of secondary peer review of extramural research grants, 
cooperative agreements, and contracts applications received in response 
to the funding opportunity announcements as they relate to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director relating to applications to be 
considered for funding support; (4) review of research portfolios, and 
(5) review of program proposals.
    Matters to be Considered: The agenda will include discussions on 
Secondary Peer Review of extramural research grant and cooperative 
agreement applications received in response to one (1) Notice of 
Funding Opportunities (NOFO): CE19-001, Injury Control Research 
Centers. Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00298 Filed 1-29-19; 8:45 am]
 BILLING CODE 4163-19-P